155 related articles for article (PubMed ID: 29463381)
21. Skin Cancer Risk of Narrow-Band UV-B (TL-01) Phototherapy: A Multi-Center Registry Study with 4,815 Patients.
Åkerla P; Pukkala E; Helminen M; Korhonen N; Karppinen T
Acta Derm Venereol; 2024 Apr; 104():adv39927. PubMed ID: 38629891
[TBL] [Abstract][Full Text] [Related]
22. Ultraviolet carcinogenesis in nonmelanoma skin cancer. Part I: incidence rates in relation to geographic locations and in migrant populations.
Almahroos M; Kurban AK
Skinmed; 2004; 3(1):29-35; quiz 35-6. PubMed ID: 14724410
[TBL] [Abstract][Full Text] [Related]
23. Carcinogenic risk in patients treated with UVA-1 phototherapy: A 5-year retrospective study.
Cosetti D; Cioppa V; Rubegni P; Trovato E
Photodermatol Photoimmunol Photomed; 2024 May; 40(3):e12975. PubMed ID: 38787937
[TBL] [Abstract][Full Text] [Related]
24. Methotrexate did not add skin cancer risk in patients with psoriasis receiving narrowband ultraviolet B phototherapy: a nationwide retrospective cohort study.
Chao CH; Wu CY; Chou FL; Chen YJ
Clin Exp Dermatol; 2024 Apr; 49(5):459-465. PubMed ID: 38056487
[TBL] [Abstract][Full Text] [Related]
25. Comparison of Phototherapy in Pediatric and Adult Patients.
Magdaleno-Tapial J; Ortiz-Salvador JM; Valenzuela-Oñate C; Marí-Cornejo P; Esteve-Martínez A; Pérez-Ferriols A
Actas Dermosifiliogr (Engl Ed); 2020 Jan; 111(1):41-46. PubMed ID: 31133298
[TBL] [Abstract][Full Text] [Related]
26. No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy: a first retrospective study.
Weischer M; Blum A; Eberhard F; Röcken M; Berneburg M
Acta Derm Venereol; 2004; 84(5):370-4. PubMed ID: 15370703
[TBL] [Abstract][Full Text] [Related]
27. Treatment with UV-B for psoriasis and nonmelanoma skin cancer: a systematic review of the literature.
Pasker-de Jong PC; Wielink G; van der Valk PG; van der Wilt GJ
Arch Dermatol; 1999 Jul; 135(7):834-40. PubMed ID: 10411159
[TBL] [Abstract][Full Text] [Related]
28. Risk of skin cancer after ultraviolet phototherapy in patients with vitiligo: a systematic review and meta-analysis.
Wu YH; Chou CL; Chang HC
Clin Exp Dermatol; 2022 Apr; 47(4):692-699. PubMed ID: 34762747
[TBL] [Abstract][Full Text] [Related]
29. Induction of Light Tolerance Using Narrowband UV-B in Solar Urticaria.
Chicharro P; Rodríguez-Jiménez P; Capusan TM; Herrero-Moyano M; de Argila D
Actas Dermosifiliogr (Engl Ed); 2018 Dec; 109(10):888-892. PubMed ID: 30205902
[TBL] [Abstract][Full Text] [Related]
30. Ultraviolet carcinogenesis in nonmelanoma skin cancer part II: review and update on epidemiologic correlations.
Almahroos M; Kurban AK
Skinmed; 2004; 3(3):132-9. PubMed ID: 15133392
[TBL] [Abstract][Full Text] [Related]
31. The effect of narrowband ultraviolet B phototherapy on antinuclear antibody status: A case-control study.
Kutlu O; Ozdemir Cetinkaya P; Karaosmanoglu N; Karaaslan E; Kiratli Nalbant E; Eksioglu M
Photodermatol Photoimmunol Photomed; 2020 Nov; 36(6):470-475. PubMed ID: 32810337
[TBL] [Abstract][Full Text] [Related]
32. Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners.
Teulings HE; Overkamp M; Ceylan E; Nieuweboer-Krobotova L; Bos JD; Nijsten T; Wolkerstorfer AW; Luiten RM; van der Veen JP
Br J Dermatol; 2013 Jan; 168(1):162-71. PubMed ID: 23136900
[TBL] [Abstract][Full Text] [Related]
33. Nonmelanoma Skin Cancer Frequency and Risk Factors in Australian Heart and Lung Transplant Recipients.
De Rosa N; Paddon VL; Liu Z; Glanville AR; Parsi K
JAMA Dermatol; 2019 Jun; 155(6):716-719. PubMed ID: 30865218
[TBL] [Abstract][Full Text] [Related]
34. The long-term risk of lymphoma and skin cancer did not increase after topical calcineurin inhibitor use and phototherapy in a cohort of 25,694 patients with vitiligo.
Ju HJ; Han JH; Kim MS; Lee SH; Shin JW; Choi M; Jeong KH; Han TY; Choi CW; Lee HJ; Oh SH; Lee SH; Kim DH; Shin J; Lee JH; Kim SS; Kang HY; Chang SE; Kim JS; Lee DY; Choi GS; Suh DH; Chan Kim Y; Park CJ; Kim KH; Lee AY; Chan Park K; Lee MH; Bae JM;
J Am Acad Dermatol; 2021 Jun; 84(6):1619-1627. PubMed ID: 33508387
[TBL] [Abstract][Full Text] [Related]
35. [Narrow-band UVB therapy in psoriasis vulgaris: good practice guideline and recommendations of the French Society of Photodermatology].
Beani JC; Jeanmougin M
Ann Dermatol Venereol; 2010 Jan; 137(1):21-31. PubMed ID: 20110064
[TBL] [Abstract][Full Text] [Related]
36. The dark side of the light: Phototherapy adverse effects.
Valejo Coelho MM; Apetato M
Clin Dermatol; 2016; 34(5):556-62. PubMed ID: 27638433
[TBL] [Abstract][Full Text] [Related]
37. Distinguishing Myth from Fact: Photocarcinogenesis and Phototherapy.
Thompson KG; Kim N
Dermatol Clin; 2020 Jan; 38(1):25-35. PubMed ID: 31753190
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology of skin cancer.
Leiter U; Eigentler T; Garbe C
Adv Exp Med Biol; 2014; 810():120-40. PubMed ID: 25207363
[TBL] [Abstract][Full Text] [Related]
39. Non-melanoma skin cancer: an evaluation of risk in terms of ultraviolet exposure.
Morales Suárez-Varela M; Llopis González A; Ferrer Caraco E
Eur J Epidemiol; 1992 Nov; 8(6):838-44. PubMed ID: 1294389
[TBL] [Abstract][Full Text] [Related]
40. Markedly reduced incidence of melanoma and nonmelanoma skin cancer in a nonconcurrent cohort of 10,040 patients with vitiligo.
Paradisi A; Tabolli S; Didona B; Sobrino L; Russo N; Abeni D
J Am Acad Dermatol; 2014 Dec; 71(6):1110-6. PubMed ID: 25242557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
